Activation of the PI3K/mTOR/AKT pathway and survival in solid tumors: systematic review and meta-analysis.
<h4>Background</h4>Aberrations in the phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR)/AKT pathway are common in solid tumors. Numerous drugs have been developed to target different components of this pathway. However the prognostic value of these aberrations is...
Saved in:
| Main Authors: | Alberto Ocana, Francisco Vera-Badillo, Mustafa Al-Mubarak, Arnoud J Templeton, Verónica Corrales-Sanchez, Laura Diez-Gonzalez, María D Cuenca-Lopez, Bostjan Seruga, Atanasio Pandiella, Eitan Amir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0095219 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment
by: Mingyang Jiang, et al.
Published: (2025-08-01) -
The Emerging Role and Clinical Significance of PI3K-Akt-mTOR in Rhabdomyosarcoma
by: Ilaria Versari, et al.
Published: (2025-02-01) -
Salidroside inhibits melanin synthesis and melanoma growth via mTOR and PI3K/Akt pathways
by: Qi Ouyang, et al.
Published: (2025-07-01) -
Microneedle‐Delivered PDA@Exo for Multifaceted Osteoarthritis Treatment via PI3K‐Akt‐mTOR Pathway
by: Zihua Li, et al.
Published: (2024-11-01) -
Therapeutic potential of sulforaphane: modulation of NRF2-mediated PI3/AKT/mTOR pathway in oral fibrosis
by: Pooja Narain Adtani, et al.
Published: (2024-04-01)